Delivery Order SPE2DB20D1051-SPE2DB25FD9KL
- Not listed
- The Defense Logistics Agency awarded a $41,840.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This is a non-set-aside competitive award with an ultimate completion date of September 3, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $53,875.27 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $34,677.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication in 3 mL vials. The contract, which is not set-aside, is scheduled for completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,497.95 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, valued at $4,744.06. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $5,877.92 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitive award, which carries a firm fixed price structure and an ultimate completion date of September 19, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and specifies...
- The Defense Logistics Agency awarded a $9,238.16 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of September 19, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $14,981.54 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and is performed from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $13,451.77 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed price contract has a completion date of July 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $5,910.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9KLDelivery Order
The Defense Logistics Agency awarded a $5,855.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) vials. This is a non-set-aside competitive award with a completion date of September 12, 2025, and performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant position within the federal medical supply chain, particularly for Defense Health Agency and military healthcare procurement. The company's SPE2DX prime IDC encompasses a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Ozempic, a diabetes medication, represents one of numerous pharmaceutical acquisitions executed through the parent contract vehicle, demonstrating AmerisourceBergen's critical role in supplying essential medications to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 9/11/25 |